Clinical Trial

Glenohumeral OsteoArthritis Therapy Trial

Study acronym: GOAT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Arthritis of the shoulder glenohumeral joint is a growing problem in an aging population. Treatment options for glenohumeral arthritis can be grouped into three main categories: 1) shoulder replacement surgery, 2) injections (corticosteroid, hyaluronic acid and PRP) and physical therapy (PT). Surgery comes with risks and the potential for implant failure or revision over time. Therefore, it is typical for doctors to prescribe injections and/or PT before discussing surgery. Sometimes, insurance companies will require PT before considering a shoulder operation. It is unknown if PT is effective for improving function or pain with patients with glenohumeral arthritis. The aim of this study is to compare pain and functional outcomes after undergoing a 12 week PT program, at home PT exercises or delaying conservative treatment.
Trial Details
NCT Number NCT07744542
Lead Sponsor State University of New York at Buffalo
Conditions Glenohumeral Arthritis, Shoulder Arthritis Osteoarthritis
Enrollment 125 participants
Start Date 2026-06-17
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-04